ENGINEERED OPSONIN FOR PATHOGEN DETECTION AND TREATMENT

    公开(公告)号:US20200291083A1

    公开(公告)日:2020-09-17

    申请号:US16892577

    申请日:2020-06-04

    摘要: The present invention provides for engineered molecular opsonins that may be used to bind biological pathogens or identify subclasses or specific pathogen species for use in devices and systems for treatment and diagnosis of patients with infectious diseases, blood-borne infections or sepsis. An aspect of the invention provides for mannose-binding lectin (MBL), which is an abundant natural serum protein that is part of the innate immune system. The ability of this protein lectin to bind to surface molecules on virtually all classes of biopathogens (viruses, bacteria, fungi, protozoans) make engineered forms of MBL extremely useful in diagnosing and treating infectious diseases and sepsis.

    SAMPLE COLLECTION SWAB
    10.
    发明公开

    公开(公告)号:US20230165571A1

    公开(公告)日:2023-06-01

    申请号:US17922518

    申请日:2021-03-19

    IPC分类号: A61B10/00 A61F13/38

    CPC分类号: A61B10/0051 A61F13/38

    摘要: The technology described herein is directed to a swab for sample collection. In one aspect, the swab comprises a sample collection head, which comprises a plurality of spaced annular rings. In one embodiment, the swab further comprises a tapered neck and a handle. In one embodiment, the swab is injection-molded using polypropylene. In other aspects, described herein are swabs comprising a water-soluble or biodegradable material. In additional aspects, described herein are kits comprising said swabs and methods of using said swabs.